CUTISS raises CHF 7.25 millions in a Series A financing
20-06-2018 – The startup of the project denovoSkin, CUTISS AG raises CHF 7.25 millions in the Series A financing round.
CUTISS AG’s lead product denovoSkin™ has successfully completed Phase I in pediatric patients and is recruiting in multi-centric Phase II studies financed by Wyss Zurich. This series A financing round is succeeding a CHF 1 million convertible loan previously provided to the company by the UZH Life Sciences Fund, and now converted.
